Literature DB >> 6415371

Macrophage activation by Lactobacillus casei in mice.

I Kato, T Yokokura, M Mutai.   

Abstract

Effects of Lactobacillus casei YIT 9018 (LC 9018), which has antitumor activities against allogeneic and syngeneic murine tumors, on macrophage functions were examined. By intraperitoneal (i.p.) injection of LC 9018, acid phosphatase activity and phagocytic activity of peritoneal macrophages were enhanced significantly compared with those of normal peritoneal macrophages. The phagocytic activities showed peaks 2-3 days after the LC 9018-injection. LC 9018 accelerated the phagocytic function of the reticuloendotherial system in ICR mice tested by the carbon clearance test. The cytostatic activity of peritoneal exudate cells (PEC) induced by i.p. injection of LC 9018 into C57BL/6 mice against EL4 cells was also enhanced. On the other hand, PEC induced by L. fermentum YIT 0159, which has no antitumor activity, did not have cytostatic activity. These observations showed that LC 9018 was able to activate macrophages in mice.

Entities:  

Mesh:

Year:  1983        PMID: 6415371     DOI: 10.1111/j.1348-0421.1983.tb00622.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  25 in total

1.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Intestinal microbiome and lymphoma development.

Authors:  Mitsuko L Yamamoto; Robert H Schiestl
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  Evaluation of immunomodulatory effects of lactic acid bacteria in turbot (Scophthalmus maximus).

Authors:  L Villamil; C Tafalla; A Figueras; B Novoa
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei.

Authors:  T Yokokura; K Nomoto; T Shimizu; K Nomoto
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

5.  Immune response in mice infected with Candida albicans in the mycelial form.

Authors:  M E Bibas Bonet de Jorrat; G A de Valdez; S F de Petrino; A Sirena; G Perdigón
Journal:  Mycopathologia       Date:  1989-05       Impact factor: 2.574

6.  Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.

Authors:  S Hashimoto; K Nomoto; T Matsuzaki; T Yokokura; M Mutai
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators.

Authors:  N Yasutake; M Ohwaki; T Yokokura; M Mutai
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

8.  Effect of perorally administered lactobacilli on macrophage activation in mice.

Authors:  G Perdigon; M E de Macias; S Alvarez; G Oliver; A A de Ruiz Holgado
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

9.  Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.

Authors:  I Kato; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  The role of lymph node cells in the inhibition of metastasis by subcutaneous injection of Lactobacillus casei in mice.

Authors:  T Matsuzaki; T Yokokura; M Mutai
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.